PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
50.26%
Net income growth above 1.5x MRVL's 4.77%. David Dodd would see a clear bottom-line advantage if it is backed by stable operations.
-2.99%
Negative yoy D&A while MRVL is 38.42%. Joel Greenblatt would note a short-term EPS advantage unless competitor invests for future advantage.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
1314.75%
Well above MRVL's 76.63% if positive yoy. Michael Burry would see a risk of bigger working capital demands vs. competitor, harming free cash flow.
No Data
No Data available this quarter, please select a different quarter.
86.58%
Some inventory rise while MRVL is negative at -10.23%. John Neff would see competitor possibly benefiting from leaner stock if demand remains.
No Data
No Data available this quarter, please select a different quarter.
315.78%
Growth well above MRVL's 427.09%. Michael Burry would see a potential hidden liquidity or overhead issue overshadowing competitor's approach.
2945.57%
Growth of 2945.57% while MRVL is zero at 0.00%. Bruce Berkowitz would see a moderate difference that might reflect intangible expansions or partial write-offs.
168.00%
Operating cash flow growth above 1.5x MRVL's 66.88%. David Dodd would confirm superior cost control or stronger revenue-to-cash conversion.
-74.11%
Both yoy lines negative, with MRVL at -52.00%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
No Data
No Data available this quarter, please select a different quarter.
-215.36%
Negative yoy purchasing while MRVL stands at 6.60%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
77.43%
Liquidation growth of 77.43% while MRVL is zero at 0.00%. Bruce Berkowitz sees a mild difference in monetizing portfolio items that must be justified by market valuations.
-25.27%
Both yoy lines negative, with MRVL at -148.62%. Martin Whitman suspects a cyclical or strategic rationale for cutting extra invests in the niche.
-136.65%
Both yoy lines negative, with MRVL at -387.62%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
No Data
No Data available this quarter, please select a different quarter.
-54.84%
Negative yoy issuance while MRVL is 589.47%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
-25.00%
We cut yoy buybacks while MRVL is 0.00%. Joel Greenblatt would question if competitor is gaining a per-share edge unless expansions justify holding cash here.